• European Unitary Patent EP4117446 Validated - Lobe Sciences secures patent protection in 17 EU member states for its DHA and egg yolk-based composition designed to manage Sickle Cell Disease.

• Covers Altemia(R) Medical Food Formula - The patented composition underpins Altemia(R), a physician-supervised medical food formulated to address long-chain fatty acid deficiencies common in SCD patients.

• Supports Global Expansion Strategy - Validation strengthens Lobe's IP portfolio and enables broader commercialization of Altemia(R) across key European markets.

From Days to Hours: MicroGenDX Ushers in Next-Day NGS Results

Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in Plasmacure B.V

Celebrating 45 Years Together: Desert Oasis Healthcare Thanks the Community for Being Part of the Journey

Empowering Everyday Health Through AI: MDCE Launches Official Site

AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory Automation

Partnership Accelerates AI Scent Intelligence Deployment in Semiconductors, Robotics and More

"At that time, I truly understood how hopeless and desperate it can feel for women trying to get pregnant naturally-before even considering expensive treatments like IVF," said Caroline. "I wanted to build something that actually remembers and respects women's history. That's what Amomi is."

With over 2,000 verified reviews and growing demand nationwide, BloodVitals is transforming how seniors track blood oxygen and heart rate levels-completely needle-free and from the comfort of home.

From Archaic to Agile: Long-Term Trends Since 2018 Highlight How Workflow Satisfaction is Redefining the Inpatient EHR Landscape

Viral demand for Real Game Used's AI authentication drives record submission volume as the company advances toward patent pending status and expands partnerships with major entertainment auction brands.

With Mira-55 and Ketamir-2, MIRA is advancing complementary non-opioid therapies for two of the largest pain markets

Amid the 2025 surge in microbiome-focused pet health innovation, UltraK9 Pro emerges as a liquid, primal nutrient-based dog supplement formulated to optimize digestive wellness, support nutrient absorption, and promote full-spectrum vitality through gut-targeted delivery.

Surging demand for at-home visual ear care fuels EaroPro's rise as a doctor-endorsed solution featuring 1080p HD camera, IP67 waterproofing, and 100Hz vibration tech - projected to lead the $4.3B ear hygiene market by 2035.

Massive 1.66 Billion Share Reduction Signals Long-Term Commitment to Shareholder Value as Company Prepares to Report Q2 Rebound Performance

July 16 Open House Highlights Expanded Sterile Filling Contract Manufacturing Capabilities for Small and Large Molecules

Newly-cleared technology is a game changer for the diagnosis of an often debilitating disease.

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to transform care

Sensifai emerges from stealth with a landmark peer-reviewed study in The Lancet Digital Health, validating its world-first AI platform to detect inflammatory events before symptoms, redefining how and when care begins.

Smile Digital Health is the first vendor to be validated by NCQA as qualified to run digital HEDIS measures with their dQM Solution.

FEATURED WORKSHOP - Introducing Empowerment-Based Integrated Treatment (EBiT)

ReadyRx - GLP-1 introduces a physician-guided support framework offering structured 3-, 6-, and 12-month access to compounded GLP-1 protocols, combining clinical oversight with habit-forming wellness strategies for sustainable weight management.

2025 Longevity Programs From ReadyRx Integrate Clinical Data, Primate Research, and TAME Trial Insights to Deliver Personalized Metformin Therapy via Secure Telehealth Platform

Golden Puppies, a Louisiana-based Golden Retriever and Goldendoodle breeder, announces donation of a Goldendoodle puppy to American Red Cross volunteer

The new 4-in-1 cardiovascular screening package helps adults over 40 detect stroke and heart attack risks early through non-invasive, physician-reviewed tests aligned with updated AHA prevention guidelines.

Designed for real-life mobility, the Toyota Sienna Hybrid FlexMaxx™ offers families and individuals a quiet, fuel-efficient and adaptable solution for everyday travel.

Initial Collaboration Launches at Yukon, OK Site

Wattbike acquisition is the latest milestone in transformational strategy and the Sportstech acquisition is on track to close in the third quarter

TRNR confirms guidance of more than $75 million in pro forma 2025 revenue and profitability in fourth quarter

TRNR's $55 million Digital Asset Treasury is actively purchasing $FET cryptocurrency

Imagene AI delivers a living intelligence engine for adaptive, insight-driven precision medicine.

Built by industry veterans, the iProElite system offers multi-modality flexibility, real-world support, and clinical protocols designed to grow with your practice.

The GOAT Collection features game-worn memorabilia from Michael Jordan, LeBron James, and Kobe Bryant; The Grail Collection to follow with high value assets from sports history's most iconic legends.

While Chinese cartels built a marijuana empire across at least six states, MMJ-a Rhode Island-based company with FDA orphan drug status-was left to rot in a bureaucratic black hole engineered by DEA Diversion officials Matthew Strait, Thomas Prevoznik, Anne Milgram and Aarathi Haig.

Clinically-informed routines backed by garlic, hawthorn berry, and hibiscus highlight Heart Freedom's botanical approach to sustained blood pressure support, circulation enhancement, and heart health integration in 2025.

The 2025 launch of the Herz P1 Smart Ring introduces a sleek, all-weather wearable that tracks sleep, stress, heart rate variability, blood oxygen, and temperature - delivering continuous health insights through a durable, low-maintenance, app-connected device.

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon (GCG) receptors

Company will also develop a subcutaneous version, PN-477sc, as a once-weekly injection

IND-enabling studies underway, with Phase I study initiation expected in 2Q26

Webcast and conference call to be held today at 4:30 pm ET

OIC International brings modular trauma systems to underserved global markets, advancing surgical care through innovation, accessibility, and regional collaboration.

Partners With ASE to Scale AI Nose Deployment and Set New Standard in Intelligent Sensing

Achieves Strategic Inflection Point in 1H 2025 with Partnerships and Operational Breakthroughs

Oral therapy designed to minimize CNS side effects shows dual activity in weight loss and smoking cessation models without muscle loss

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older

Retirements Reported in DEA's DIVERSION as "DOGE CASUALTIES".

Fueled by screen fatigue, blue light exposure, and age-related eye concerns, Visiultra's science-backed formula featuring lutein, zeaxanthin, and astaxanthin is gaining traction among adults seeking daily vision support and long-term ocular clarity in 2025.

Survey findings underscore significant improvements in medical practice denial management, patient engagement, and operational efficiency driven by advanced technologies.